INTRODUCTION
============

Cutaneous lupus erythematosus in a linear configuration is rare, especially in children. Less than 2% of cases appear before age 10.^[@r1]^ It affects equally both genders, shows no photosensitivity and less probability of evolution to systemic disease.^[@r2]^ The term linear cutaneous lupus erythematosus (LCLE) is currently employed since clinical lesions lack the classic discoid shape.^[@r3]^

Such linear configuration follows the lines of Blaschko, which were described for the first time in 1901 by Alfred Blaschko, who reported the presence of several linear diseases with characteristic disposition.^[@r4]^

We describe a 9-year-old patient with, papular and erythematous lesions with central atrophy on the upper and lower right limbs, asymptomatic, and following the lines of Blaschko. We highlight the unusual clinical presentation of this disorder.

CASE REPORT
===========

Female patient, 9-year-old, phototype IV, presented a history of onset of papular and erythematous cutaneous lesions, some violaceous, with central atrophy and asymptomatic, since age 4. Such lesions had a linear appearance, following the lines of Blaschko, on the upper and lower right limbs ([Figures 1](#f1){ref-type="fig"} - [4](#f4){ref-type="fig"}). There were no reports of similar cases in the family or history of trauma or photosensitivity.

Figure 1Erythematous brownish papules with central atrophy, following the lines of Blaschko, on the upper right limb

Figure 4Erythematous purplish papules presenting central atrophy, on the side of right thigh

A biopsy revealed atrophy of the epidermis, with aggression of epidermal-dermal interface and periadnexal and perivascular lymphocytic inflammatory infiltrate ([Figure 5](#f5){ref-type="fig"}). Additionally, PAS staining showed thickening and irregularities of the basement membrane ([Figure 6](#f6){ref-type="fig"}). ANA was postive (1:320, dense fine speckled pattern) and other laboratory test did not show systemic involvement.

Figure 5Epidermal atrophy, perivascular and periadnexal dermal inflammatory infiltrate, and vacuolization of basal layer (aggression of epidermal-dermal interface) (HE, 40x)

Figure 6Basal layer thickening (PAS, 400x)

Treatment with hydroxychloroquine (150 mg/day) was instituted with gradual remission. No relapse was observed within a one-year follow-up.

DISCUSSION
==========

Cutaneous lupus erythematosus has many clinical presentations, divided in acute, subacute and chronic. Its linear presentation is very uncommon (than 20 cases described), especially when the most involved site - the face - is not affected.^[@r5]^

The origin of the lines of Blaschko remains controversial, with two theories explaining the pathogenesis. According to the first one, these lines may be the result of a mosaicism of cutaneous cells, in which there would be two or more distinct cell populations, originated from a genetically homogeneous zygote, arising from a somatic mutation, functional disparity of the X chromosome or gonadal genetic mutation. The second theory proposes that the lines of Blaschko result from an isolated cutaneous segmentary growth.^[@r6]^

Several inflammatory dermatoses follow the lines of Blaschko or present linear configurations. It is necessary to perform a differential diagnosis between LCLE and striated lichen, psoriasis, morphea, lichen planus and especially lichen sclerosus and atrophic.^[@r7]^

The majority of patients described in the literature developed the disease during childhood, with an average age of 15.8 (ranging from 3 to 42 years) and an average of one year and a half between the onset of lesions and diagnosis. There were lesions that followed the lines of Blaschko in all patients, and they could be seen mainly on the face and neck, demonstrating the most typical presentation of the disease. The involvement of members and body was uncommon and, in the majority of cases, only a single anatomical site was affected.^[@r8]^

All published cases presented histological confirmation of lesions. In cases in which the histological diagnosis is unclear, direct immunofluorescence is recommended, in which granular deposits of IgM, IgG and IgA and complement in the dermo-epidermal junction zone and around dermal vessels can be observed. Such procedure is not mandatory for confirmation of the disease.^[@r9]^

LCLE in childhood presents less probability of evolving to systemic disease. In published studies, few patients presented positive ANA, in low titers (1:80), predominantly in homogeneous or speckled pattern. No systemic involvement has been reported.^[@r9]^

Hydroxy-chloroquine, a first-line drug, promotes remission of lesions in most cases along with a favorable safety profile. Dapsone, methotrexate, moderate to high potency topical corticosteroids and topical calcineurin inhibitors can also be employed in patients that are unresponsive to hydroxyxchloroquine or when this drug is contraindicated.^[@r10]^

The case presented shows the involvement of the limbs in two distinct anatomical sites, following the lines of Blaschko, in a child whose age group is compatible with described cases of LCLE. Additional investigations, based on clinical (such as photosensitivity and renal, hepatic, hematologic, neurological and inflammatory functions) and immunological criteria, yielded positive ANA results (1:320), a dilution higher than usual for such cases.

Linear lichen planus, or zosteriform, is the most important differential diagnosis. Similar histological findings in hematoxylin-eosin staining, such as liquefaction degeneration of the basal layer and the presence of lymphocytary infiltrate, were associated with features of LCLE such as epidermal atrophy, follicular plugging and perivascular and periadnexal infiltrate, infrequent hypergranuloisis and fewer colloid bodies. Thickening of the basal membrane could be demonstrated by PAS staining, providing the histological diagnosis of LCLE.

The prescribed treatment was adequate to inhibit the activity of the disease, and after its implementation there was gradual improvement of lesions. Additional medications were not introduced. The reported case demonstrates an atypical presentation of LCLE in view of its rarity, clinical picture and topography of lesions, reasons why describing it was considered important.
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